“HIGH-DOSE-RATE BRACHYTHERAPY FOR PROSTATE CANCER: DIRECT IN VIVO DOSIMETRY IS AN IMPORTANT FACTOR IN INCREASING THE EFFECTIVENESS OF TREATMENT AND REDUCING THE INCIDENCE OF COMPLICATIONS”. Voprosy Onkologii, vol. 65, no. 4, Apr. 2019, pp. 596-02, https://doi.org/10.37469/0507-3758-2019-65-4-596-602.